These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 23531645)

  • 1. Short-term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy.
    Kim SH; Lee JH; Ryu HW; Lim BC; Chae JH; Choi JE; Hwang YS; Kim KJ
    Epileptic Disord; 2013 Mar; 15(1):49-54. PubMed ID: 23531645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and tolerability of rufinamide in children and young adults with Lennox-Gastaut syndrome: a single center study in Korea.
    Lee EH; Yum MS; Ko TS
    Clin Neurol Neurosurg; 2013 Jul; 115(7):926-9. PubMed ID: 23083943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: the first Italian prospective study.
    Moavero R; Cusmai R; Specchio N; Fusco L; Capuano A; Curatolo P; Vigevano F
    Epilepsy Res; 2012 Nov; 102(1-2):94-9. PubMed ID: 22677424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience.
    Coppola G; Grosso S; Franzoni E; Veggiotti P; Zamponi N; Parisi P; Spalice A; Habetswallner F; Fels A; Capovilla G; Verrotti A; Mangano S; Balestri A; Curatolo P; Pascotto A
    Seizure; 2010 Nov; 19(9):587-91. PubMed ID: 20888268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with rufinamide in a pediatric population: a single center's experience.
    Vendrame M; Loddenkemper T; Gooty VD; Takeoka M; Rotenberg A; Bergin AM; Eksioglu YZ; Poduri A; Duffy FH; Libenson M; Bourgeois BF; Kothare SV
    Pediatr Neurol; 2010 Sep; 43(3):155-8. PubMed ID: 20691934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome.
    Mueller A; Boor R; Coppola G; Striano P; Dahlin M; von Stuelpnagel C; Lotte J; Staudt M; Kluger G
    Epilepsy Behav; 2011 Jul; 21(3):282-4. PubMed ID: 21620771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First long-term experience with the orphan drug rufinamide in children with myoclonic-astatic epilepsy (Doose syndrome).
    von Stülpnagel C; Coppola G; Striano P; Müller A; Staudt M; Kluger G
    Eur J Paediatr Neurol; 2012 Sep; 16(5):459-63. PubMed ID: 22266062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rufinamide as an adjuvant treatment in children with Lennox-Gastaut syndrome.
    Kim SH; Eun SH; Kang HC; Kwon EJ; Byeon JH; Lee YM; Lee JS; Eun BL; Kim HD
    Seizure; 2012 May; 21(4):288-91. PubMed ID: 22421185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epilepsy with myoclonic absences - favourable response to add-on rufinamide treatment in 3 cases.
    Häusler M; Kluger G; Nikanorova M
    Neuropediatrics; 2011 Feb; 42(1):28-9. PubMed ID: 21557146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vagus nerve stimulation: effectiveness and tolerability in 64 paediatric patients with refractory epilepsies.
    Cersósimo RO; Bartuluchi M; Fortini S; Soraru A; Pomata H; Caraballo RH
    Epileptic Disord; 2011 Dec; 13(4):382-8. PubMed ID: 22258042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rufinamide in children and adults in routine clinical practice.
    Jaraba S; Santamarina E; Miró J; Toledo M; Molins A; Burcet J; Becerra JL; Raspall M; Pico G; Miravet E; Cano A; Fossas P; Fernández S; Falip M
    Acta Neurol Scand; 2017 Jan; 135(1):122-128. PubMed ID: 26923380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.
    Wisniewski CS
    Ann Pharmacother; 2010 Apr; 44(4):658-67. PubMed ID: 20233912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of rufinamide in children under four years of age with drug-resistant epilepsies.
    Grosso S; Coppola G; Dontin SD; Gobbi G; Pruna D; Accorsi P; Verrotti A; Parisi P; Balestri P
    Eur J Paediatr Neurol; 2014 Sep; 18(5):641-5. PubMed ID: 24912730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epileptic syndromes: differential treatment in infants, children, and adolescents.
    Foulon M; Aeby A; Buzatu M; Christiaens F; de Borchgrave V; de Cocq C; de Tourtchaninoff M; Dubru JM; Ghariani S; Grisar T; Legros B; Lienard F; Ossemann M; Tugendhaft P; van Bogaert P; van Rijckevorsel K; Verheulpen D; Vrielynck P;
    Acta Neurol Belg; 2011 Sep; 111(3):175-82. PubMed ID: 22141279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rufinamide: a new antiepileptic drug treatment for Lennox-Gastaut syndrome.
    Ferrie CD
    Expert Rev Neurother; 2010 Jun; 10(6):851-60. PubMed ID: 20518600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy.
    Lee YJ; Kang HC; Seo JH; Lee JS; Kim HD
    Brain Dev; 2010 Mar; 32(3):208-12. PubMed ID: 19304420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.
    McCormack PL
    Pharmacoeconomics; 2012 Mar; 30(3):247-56. PubMed ID: 22332960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome after callosotomy or vagus nerve stimulation in consecutive prospective cohorts of children with Lennox-Gastaut or Lennox-like syndrome and non-specific MRI findings.
    Cukiert A; Cukiert CM; Burattini JA; Lima AM; Forster CR; Baise C; Argentoni-Baldochi M
    Seizure; 2013 Jun; 22(5):396-400. PubMed ID: 23490456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview.
    Wier HA; Cerna A; So TY
    Paediatr Drugs; 2011 Apr; 13(2):97-106. PubMed ID: 21351809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.